Jorge. E Romero, MD, FHRS, FACC is Director of the Arrhythmia and Electrophysiology Research Program and Associate Director of the Ventricular Arrhythmia Program at Brigham and Women's Hospital. He is also a member of the faculty at Harvard Medical School.
Dr. Romero completed his internship and residency in internal medicine at St Luke's Roosevelt Hospital/Columbia University. His cardiovascular fellowship was at Montefiore Medical Center/Albert Einstein College of Medicine where he obtained the cardiology fellowship training program director's Award. Subsequently, he completed his cardiac electrophysiology fellowship at Ronald Regan Medical Center/UCLA and Brigham and Women's Hospital /Harvard Medical School. He is currently a quadruple board-certified physician for the American Board of Internal Medicine, Cardiovascular Disease, Cardiac Clinical Electrophysiology, and the National Board of Echocardiography. In addition, he is a fellow of the American College of Cardiology (FACC) and the Heart Rhythm Society (FHRS).
His clinical interests include treating complex arrhythmias, particularly in endocardial-epicardial mapping and catheter ablation of ventricular tachycardia and managing patients with persistent and long-standing persistent atrial fibrillation. He has pioneered cutting-edge approaches and techniques to eliminate these two arrhythmias. He is also interested in minimizing the periprocedural stroke risk of catheter ablation of both atrial and ventricular arrhythmias.
Dr. Romero has published over 170 research investigations in top-tier journals and authors. He has author and coauthors more than 20 book chapters. Given his extensive contributions in the field over the last few years, he has been invited to present at multiple Heart Rhythm Society meetings (HRS). He has been awarded two Young Investigator Awards—one from the American Heart Association and the other from the American Society of Hypertension. He also received The Eric N. Prystowsky Early Career Researcher Award at the Heart Rhythm Society Scientific meeting in 2018 for describing a novel PVC ablation technique using an intracoronary wire mapping and a coronary reentry system. Dr. Romero is the principal global investigator for the PLEA trial (NCT04216667). This trial is a prospective international multicenter randomized controlled trial that has the overall goal of establishing the efficacy and safety of different ablation techniques for patients with persistent and long-standing persistent atrial fibrillation.
